Michael Thomas Heffernan

Insider Reports History

Location
Wayne, PA
Signature
/s/ Lee Giguere, as attorney-in-fact for the Reporting Person
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Thomas Heffernan:

Company Role Class Num Shares Value Price $ Report Date Ownership
COLLEGIUM PHARMACEUTICAL, INC Director Common Stock 50,328 $1,536,011 $30.52 10 Feb 2025 Direct
Akebia Therapeutics, Inc. Director Common Stock 48,586 $59,416 $1.22 02 Jun 2021 Direct
enGene Holdings Inc. Director Stock Option (Right to Buy) 45,000 08 Jul 2025 Direct
Trevi Therapeutics, Inc. Director Nonstatutory Stock Option (right to buy) 45,000 11 Jun 2025 Direct
Biohaven Ltd. Director Stock Options (Right to buy) 31,716 05 May 2025 Direct
SYNLOGIC, INC. Director Stock Option (right to buy) 30,000 22 Jun 2023 Direct
Avalo Therapeutics, Inc. Director Stock Option (Right to Buy) 29,500 17 Jun 2025 Direct
Akebia Therapeutics, Inc. Director Stock Option (Right to buy) 20,100 02 Jun 2021 Direct
Biohaven Pharmaceutical Holding Co Ltd. Director Restricted Share Unit Award 0 03 Oct 2022 Direct
Biohaven Pharmaceutical Holding Co Ltd. Director Stock Options (Right to Buy) 0 03 Oct 2022 Direct

Insider Reports Filed by Michael Thomas Heffernan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENGN enGene Holdings Inc. 08 Jul 2025 1 $0 4 Director 10 Jul 2025, 16:06
ENGN enGene Holdings Inc. 08 Jul 2025 0 $0 3 Director 08 Jul 2025, 16:13
AVTX Avalo Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 16:19
TRVI Trevi Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 13 Jun 2025, 16:00
BHVN Biohaven Ltd. 05 May 2025 1 $0 4 Director 07 May 2025, 17:15
AVTX Avalo Therapeutics, Inc. 25 Mar 2025 1 $0 4 Director 26 Mar 2025, 16:07
AVTX Avalo Therapeutics, Inc. 25 Mar 2025 0 $0 3 Director 26 Mar 2025, 16:01
COLL COLLEGIUM PHARMACEUTICAL, INC 10 Feb 2025 1 $0 4 Director 12 Feb 2025, 16:10
TRVI Trevi Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:30
COLL COLLEGIUM PHARMACEUTICAL, INC 16 May 2024 1 $0 4 Director 16 May 2024, 19:21
BHVN Biohaven Ltd. 30 Apr 2024 1 $0 4 Director 02 May 2024, 19:33
TRVI Trevi Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 30 Jun 2023, 16:00
SYBX SYNLOGIC, INC. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 14:20
COLL COLLEGIUM PHARMACEUTICAL, INC 18 May 2023 1 $0 4 Director 19 May 2023, 16:40
BHVN Biohaven Ltd. 02 May 2023 1 $0 4 Director 04 May 2023, 17:51
COLL COLLEGIUM PHARMACEUTICAL, INC 22 Dec 2022 12 -$186,039 4 Director 27 Dec 2022, 18:17
COLL COLLEGIUM PHARMACEUTICAL, INC 19 Dec 2022 9 -$583,124 4 Director 21 Dec 2022, 18:28
COLL COLLEGIUM PHARMACEUTICAL, INC 12 Dec 2022 14 -$1,334,765 4 Director 14 Dec 2022, 17:06
BHVN Biohaven Ltd. 03 Oct 2022 1 -$72,742 4/A Director 12 Oct 2022, 18:31
BHVN Biohaven Pharmaceutical Holding Co Ltd. 03 Oct 2022 4 $0 4 Director 03 Oct 2022, 20:26
BHVN Biohaven Ltd. 28 Sep 2022 0 $0 3 Director 30 Sep 2022, 16:33
TRVI Trevi Therapeutics, Inc. 23 Jun 2022 1 $0 4/A Director 01 Jul 2022, 16:56
SYBX SYNLOGIC, INC. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:15
COLL COLLEGIUM PHARMACEUTICAL, INC 19 May 2022 1 $0 4 Director 23 May 2022, 17:53
BHVN Biohaven Pharmaceutical Holding Co Ltd. 28 Apr 2022 1 $0 4 Director 29 Apr 2022, 20:58
BHVN Biohaven Pharmaceutical Holding Co Ltd. 20 Dec 2021 1 $0 4 Director 22 Dec 2021, 20:51
TRVI Trevi Therapeutics, Inc. 16 Jun 2021 1 $0 4 Director 17 Jun 2021, 16:01
SYBX SYNLOGIC, INC. 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:08
AKBA Akebia Therapeutics, Inc. 02 Jun 2021 2 $0 4 Director 03 Jun 2021, 17:27
COLL COLLEGIUM PHARMACEUTICAL, INC 20 May 2021 1 $0 4 Director 24 May 2021, 17:19
BHVN Biohaven Pharmaceutical Holding Co Ltd. 05 May 2021 1 $0 4 Director 07 May 2021, 16:33